
News|Articles|July 1, 2004
Incretin mimetics improve glycemic control in type 2 diabetes
Release of GLP-1 in responseto an ingested meal and glucose load plays a major role in the development of impaired insulin secretion.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Real-World Usage of Biologics in Psoriatic Arthritis
3
Researchers discover new pathway to fight liver inflammation
4
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
5





















